Baxter International (BAX) PT Raised to $95 at BMO Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil rally pressures S&P, Nasdaq; Microsoft, Salesforce buoy Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Lumentum shares fall after hitting 52-week high
Baxter Reports Second-Quarter 2019 Results
July 25, 2019 7:15 AM EDT- Anticipates $500 million investment to support Advancing American Kidney Health Initiative - Â
Second quarter revenue of $2.8 billion was comparable year over year on a reported basis; increased 4% on an operational basis Second quarter GAAP earnings per share (EPS) of $0.66 increased 5%; Adjusted EPS of $0.89 increased 16% Baxter expects full-year 2019 GAAP EPS of $2.81 to $2.89; Adjusted EPS of $3.34 to $3.401 Company is committed to help drive home dialysis adoption in line with U.S. Department of Health and Human Services (HHS) goals and anticipates significant investment to support... More


